Patient Data Exhibits For each action, identify if it is indicated or not indicated when monitoring the effects of lorazepam administration. Each row must have one response action selected.

Rationale: Count the respirations: Lorazepam is a benzodiazepine that can cause respiratory depression, especially when given IV. Regular monitoring of respiratory rate helps detect hypoventilation early. Listen for heart palpitations: While the client initially had atrial tachycardia, monitoring palpitations is not a priority in evaluating lorazepam’s effectiveness, which focuses more on CNS and respiratory status. Assess for constipation: Constipation is not an acute or common side effect associated with single-dose IV lorazepam. It is not relevant in short-term monitoring. Evaluate client for motor coordination: Benzodiazepines like lorazepam may impair psychomotor function. Assessing coordination can help monitor CNS depressant effects and safety. Observe level of consciousness: Altered LOC is a common side effect of lorazepam due to its sedative properties. Ongoing neurological checks are essential. Monitor for drowsiness: Drowsiness is a common and expected effect of lorazepam. Monitoring helps determine if the sedative effect is appropriate or excessive.